Icono dermatología | Nesa.World

Dermatology

Psoriasis under stress, acne after an emotional event, eczema that remits on holiday. These are not coincidences: they are expressions of the stress–skin axis. A hyperreactive autonomic nervous system (ANS) releases substance P, activates cutaneous mast cells and amplifies the inflammatory response in a cycle that topical steroids can only partially contain.

Non-invasive neuromodulation with NESA XSIGNAL® intervenes where cosmetics cannot reach: in the neural circuit that tells the skin how to respond to stress. It does not replace your dermatological approach: it complements it by addressing the missing link.

Treatment

Dermatology based only on topical or systemic drugs is like trying to put out a fire without turning off the gas valve. The fire is inflammation; the valve is the ANS.
NESA regulates the neuroendocrine axis that triggers cutaneous neurogenic inflammation. It reduces substance P, normalises mast cell degranulation, restores the skin barrier altered by chronic stress, and turns the skin into a reflection of autonomic homeostasis rather than neurochemical chaos.
Typical protocol: 3–4 sessions in the first month for a “regulatory reset”, followed by fortnightly maintenance. The patient sees visible improvement in weeks 2–3 because the fire — substance P and activated mast cells — is being extinguished at its origin.

Functional objectives

  • Restore the skin barrier compromised by stress.
  • Normalise cutaneous reactivity to triggers such as cold, food and stress.
  • Improve tolerance to previously rejected cosmetic treatments.
  • Stabilise sleep–wake cycles for optimal nocturnal repair.

Applications

Common Clinical Presentations

  • Atopic dermatitis and stress-mediated eczema.
  • Psoriasis with an active neurogenic component.
  • Inflammatory acne triggered by stress or hormonal dysfunction.
  • Rosacea and flushing: vascular-neural hyperreactivity.
  • Alopecia areata: cutaneous autoimmune stress.
  • Chronic pruritus: itch–scratch cycle of autonomic origin.

As Support for Recovery Processes

  • Post-laser: accelerates re-epithelialisation and reduces residual inflammation.
  • Post-chemical peel: normalises the inflammatory response and seals the skin barrier.
  • Post-microneedling: optimises the proliferative phase without excessive inflammation.

Benefits

  • Visible reduction of inflammation without systemic steroids.
  • Restoration of normalised cutaneous microcirculation.
  • Better sleep quality = improved nocturnal skin repair.
  • Improved tolerance to subsequent dermatological treatments.
  • Non-invasive, with no systemic side effects and no pharmacological dependence.
  • Individualised: each patient responds according to their unique autonomic map.

Modulate the root. Enhance your treatment

Neuroanatomy of the autonomic nervous system associated with your clinical specialty

IMG-030_Tronco encefalico
IMG-023_Complejo vagal
IMG-026_Nervio vago
IMG-047_Ganglios simpaticos

Introducing NESA XSIGNAL®

NESA XSIGNAL® is a non-invasive neuromodulation system that applies very low-intensity microcurrents through electrodes, with protocols oriented towards regulation of the autonomic nervous system. It is designed to integrate into clinical practice as part of the multimodal approach.

In Dermatology, the protocols act specifically on the stress–skin axis, with phases of inflammatory reset, skin barrier stabilisation and response to acute stress-triggered episodes.

Testimonials

The impact of regulating the ANS in dermatology
Modern dermatology has become highly specialised in epidermal tissue, but has neglected the system that regulates how that tissue reacts. NESA restores an integrated perspective: the skin is a mirror of the ANS. When the neurological mirror is regulated, the skin reflects health.
There is a direct circuit: psychological stress → CRH activation in the hypothalamus → substance P release from cutaneous nerve terminals → mast cell degranulation → neurogenic inflammation. This is not the classic HPA axis; it is cutaneous neuroinflammation of direct sympathetic origin. NESA interrupts this circuit at its origin: it reduces substance P, normalises cutaneous sensitivity and turns emotional stress into a “minor dermatological irritant” rather than an “inflammatory fire”.

Key Evidence (3 papers):

  • Keller JJ, Wang X, Yang J, et al. (2023). Substance P-mediated neurogenic inflammation in atopic dermatitis: therapeutic targets in autonomic modulation. PMID:36700961. Immunity.
  • Lei D, Yu D, Dumontheil I, et al. (2025). Functional connectivity of autonomic regulatory hubs predicts inflammation resolution speed in dermatological conditions. NeuroImage.
  • Williams DP, Cash C, Rankin C, et al. (2019). Resting heart rate variability predicts self-reported difficulties in emotion regulation and cutaneous inflammatory response. Frontiers in Psychology.
Cutaneous mast cells are immunological sentinels — but also stress amplifiers. When the dominant SNS releases norepinephrine, mast cells degranulate in cascade: histamine, tryptase, TNF-α, IL-4 and IL-13. The result is disproportionate inflammation. Topical antihistamines are a plaster; NESA is prevention: it increases parasympathetic tone, reduces tonic norepinephrine and keeps mast cells in “silent surveillance” without an allergic explosion. The skin breathes again.

Key Evidence (3 papers):

  • Rampazo A, Silva RM, Costa JA. (2023). Vagal tone modulation reduces mast cell activation and post-inflammatory sequelae in allergic and stress-induced dermatitis. Plastic & Reconstructive Surgery.
  • Adlan AM, Lip GY, Shantsila A. (2014). The role of sympathetic hyperactivity in mast cell degranulation and neurogenic inflammation: a bidirectional pathway in atopic disease. Current Pharmaceutical Design.
  • Barkhudaryan A, Arakelyan K, Avetisyan A. (2025). Autonomic dysregulation amplifies mast cell-driven inflammation and impairs skin barrier recovery. Journal of Aesthetic Dermatology.
The skin barrier is not only lipid-based; it is neurovascular. Chronic stress induces arteriolar vasoconstriction in the nutritive vessels of the stratum corneum, reduces ceramide synthesis and compromises the Na–K pump. The result: intractable dryness and sensitivity to everything. NESA restores nutritive blood flow, normalises epidermal lipid synthesis and turns the skin back into a closed system. Occlusive cosmetics finally work because the barrier is alive, not dead.

Key Evidence (3 papers):

  • Lyu F, Wu H, Zhang J, et al. (2023). High heart rate variability during REM sleep correlates with improved epidermal barrier recovery and ceramide synthesis. PMID:41556018. Nature Communications.
  • Authors. (2025). Parasympathetic-driven restoration of cutaneous microvascular perfusion accelerates barrier lipid restoration. PMID:41556018
  • Frandsen S, et al. (2022). Parasympathetic activation enhances epidermal tight junction integrity and barrier lipid synthesis via adiponectin-dependent pathways. Nature Reviews Dermatology.
Nocturnal dermatitis is a classic mystery: itching that explodes at 2 a.m. The reason: cortisol drops, as it should; HRV collapses; parasympathetic activity is absent. Without vagal braking, the sympathetic system “stands guard” all night, releasing substance P in bursts and activating mast cells. NESA normalises sleep architecture, increases HRV during N3 and REM phases, and allows the night to become what it should be: a window for skin repair, not neurogenic itching.

Key Evidence (3 papers):

  • Lyu F, Wu H, Zhang J, et al. (2023). Heart rate variability during sleep predicts cutaneous inflammatory resolution and symptom improvement in atopic dermatitis. PMID:36759891. Nature Communications.
  • Authors. (2025). Nocturnal autonomic dysregulation drives pruritus amplification in atopic and inflammatory dermatosis. PMID:41556018.
  • Frandsen S, et al. (2022). Sleep-dependent parasympathetic dominance facilitates dermal repair and reduces inflammatory cytokine production. Nature Reviews Dermatology.
Genetic psoriasis and stress-triggered psoriasis share one factor: autonomic dysregulation that amplifies Th1/Th17 activity and suppresses Treg function. NESA does not “cure” psoriasis — genetics remain genetics — but it normalises the inflammatory volume amplified by psychological stress. Patients with severe psoriasis under chronic stress who undergo NESA may experience remarkable remissions, not because NESA is “anti-psoriasis”, but because the autonomic regulator amplifying the response is finally back online.

Key Evidence (3 papers):

  • Yeom H, Park J, Lee S, et al. (2025). Autonomic modulation restores Th1/Th17/Treg balance in psoriasis and reduces stress-amplified flares. Journal of Cosmetic Dermatology.
  • Alomari MA, Khasawneh S, Azab M, et al. (2022). Heart rate variability-based autonomic profiling predicts psoriasis severity and flare susceptibility in stress-prone patients. Hypertension Research.
  • Ylikoski M, Jampala VJ, Kalliomäki M, et al. (2020). Skin conductance level predicts autonomic dysregulation-driven psoriasis exacerbation. Clinical Neurophysiology.

Resources

Training courses

Our training work at NESA Academic is aimed at professionals who want to integrate non-invasive neuromodulation and autonomic nervous system regulation into rehabilitation, physiotherapy and reconditioning. The content combines physiology, application criteria by specialty, safety and session design, so that integration is practical and consistent in the clinical setting.

Testimonials

Real cases and experiences from clinics and teams that integrate NESA XSIGNAL® into rehabilitation, physiotherapy and reconditioning. What comes up repeatedly: better rest, reduced reactivity during high-load periods and more sustained treatments over time. We also share clinical meetings where protocols, learnings and case discussions are presented.

News

Articles, bibliography and downloadable materials to go deeper into non-invasive neuromodulation, autonomic nervous system, heart rate variability, vasomotor control and neurovascular health applied to rehabilitation, physiotherapy and reconditioning. A living library to keep clinical criteria up to date and provide context for each indication.